Reasons why West Africa continues to be a hotbed for hepatocellular carcinoma.

Tognarelli, Joshua; Ladep, Nimzing G; Crossey, Mary M E; Okeke, Edith; Duguru, Mary; Banwat, Edmund; Taylor-Robinson, Simon D

Tognarelli, Joshua; Ladep, Nimzing G; Crossey, Mary M E; Okeke, Edith; Duguru, Mary; Banwat, Edmund; Taylor-Robinson, Simon D.

Afiliación

Tognarelli J; Department of Medicine, Imperial College London, St Mary's Campus, London, United Kingdom.
Ladep NG; Department of Medicine, Imperial College London, St Mary's Campus, London, United Kingdom; Department of Medicine, Jos University Teaching Hospital, Jos, Nigeria; Digestive Diseases Unit, Aintree University Hospital NHS Foundation Trust, Liverpool, United Kingdom.
Crossey MM; Department of Medicine, Imperial College London, St Mary's Campus, London, United Kingdom; Department of Medicine, Jos University Teaching Hospital, Jos, Nigeria.
Okeke E; Department of Medicine, Jos University Teaching Hospital, Jos, Nigeria.
Duguru M; Department of Medicine, Jos University Teaching Hospital, Jos, Nigeria.
Banwat E; Department of Medicine, Jos University Teaching Hospital, Jos, Nigeria.
Taylor-Robinson SD; Department of Medicine, Imperial College London, St Mary's Campus, London, United Kingdom.

Niger Med J ; 56(4): 231-5, 2015.

Article en En | MEDLINE | ID: mdl-26759504

Palabras clave

Aflatoxin; hepatitis B; hepatitis C; hepatocellular carcinoma; liver cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Niger Med J Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google